ARCG Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
19:35
Jun 24
Avi Felman Principal, GoldenTree Asset Management 1000x Podcast
Biotech re-rates on AI drug discovery
AI will radically change the biotech industry by enabling cheaper and faster drug discovery, causing the entire sector to rerate higher. Since picking single stocks is hard, the best way to play this is via diversified biotech ETFs, with a 70/30 split between XBI (broad) and ARCG (high-octane).
ARCG 1ST
HIGH

About ARCG Analyst Coverage

Buzzberg tracks ARCG across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked. Past 7 days: 1 bullish. Latest voices: Avi Felman.